Why CrowdStrike Plunged Second Day in a Row: Key Takeaways
CrowdStrike faced a sharp sell-off for a second consecutive day after a sector-wide reaction to new AI security produ...
Compare how robo advisor fees stack up against potential returns to help you decide if automation fits your investing plan. This intro explains the core cost-benefit idea in plain terms.
22,067 articlesCrowdStrike faced a sharp sell-off for a second consecutive day after a sector-wide reaction to new AI security produ...
A single public remark can ripple through the arts ecosystem and even into personal finances. This article explains h...
Two Harbors Investment will terminate its merger with UWM and accept an all-cash bid from CrossCountry worth roughly ...
ClearPoint’s early-2026 earnings signal a busy year ahead. This analysis breaks down revenue, margins, guidance, and ...
CrowdStrike stock just 52-week highs signal strong momentum, but investors must weigh the run-up against real growth....
Eli Lilly’s GLP-1 drugs have changed the game in obesity and diabetes. This article explains why Lilly Sees More Deal...
PowerFleet is reshaping fleet management with AI-powered IoT. This guide breaks down what to expect from powerfleet (...
Today’s market moves show a tech-led rotation and Meta’s cloud pivot stealing the spotlight. Here’s what it means for...
Warren Buffett resurfaces on CNBC as Berkshire Hathaway shares retreat, highlighting leadership transition questions ...
Rivian faces a challenging journey into 2026, with big questions about profitability, demand, and policy shifts. This...
As the calendar closes on 2025, Ascendis (ASND) faces the final earnings closeout with questions about cash, pipeline...
C3.AI has faced a rough run, leaving investors wondering if a comeback is possible. This article breaks down the fact...